Comparative Contralateral Randomized Clinical Trial of Standard (3 mW/cm<sup>2</sup>) Versus Accelerated (9 mW/cm<sup>2</sup>) CXL in Patients With Down Syndrome: 3-Year Results. | J Refract Surg;38(6): 381-388, 2022 Jun. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Comparative Contralateral Randomized Clinical Trial of Standard (3 mW/cm²) Versus Accelerated (9 mW/cm²) CXL in Patients With Down Syndrome: 3-Year Results.

Hashemi, Hassan; Roberts, Cynthia J; Ambrósio, Renato; Mehravaran, Shiva; Hafezi, Farhad; Vinciguerra, Riccardo; Vinciguerra, Paolo; Panahi, Parsa; Asgari, Soheila.

J Refract Surg ; 38(6): 381-388, 2022 Jun.

Article in En | MEDLINE | ID: mdl-35686709

Subject(s)

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Photochemotherapy / Down Syndrome / Keratoconus Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: J Refract Surg Journal subject: OFTALMOLOGIA Year: 2022 Document type: Article Country of publication:

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Photochemotherapy / Down Syndrome / Keratoconus Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: J Refract Surg Journal subject: OFTALMOLOGIA Year: 2022 Document type: Article Country of publication: